The effect of Morus nigra mouthwash on mucositis

Evaluation of the effect of Morus nigra mouthwash on chemotherapy induced oral mucositis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070234857N1

Enrollment

Registered

2017-08-03

Start date

2017-08-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced oral mucositis. Oral mucositis (ulcerative)

Interventions

Intervention 1: intervention gourp: administration of Morus nigra mouthwash, three times a day up two weeks, each time at 10 cc. Intervention 2: Control group: receives placebo.

Treatment - Drugs

Placebo

intervention gourp: administration of Morus nigra mouthwash, three times a day up two weeks, each time at 10 cc

Control group: receives placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria :full awareness; oral mucosal health; non-autoimmune diseases; non-use of drugs; alcohol; cigarettes ; other oral mucus solutions during research and non-treatments such as radiation therapy. exclusion criteria: Do not cooperate with the patient in using mouthwash

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of oral mucositis. Timepoint: Before the intervention, one week after the intervention, two weeks after the intervention. Method of measurement: WHO indices.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ghasemzadeh

Sari Dentistry College

Dr.Meysam.Yazdian@gmail.com+98 11 3324 4014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026